Boston Scientific (BSX) Total Debt Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.93% |
| Dec 31, 2025 | 4.58% |
| Sep 30, 2025 | 200.93% |
| Jun 30, 2025 | 224.91% |
| Mar 31, 2025 | 255.20% |
| Dec 31, 2024 | 1.43% |
| Sep 30, 2024 | 0.00% |
| Jun 30, 2024 | 2.07% |
| Mar 31, 2024 | 2.85% |
| Dec 31, 2023 | 5.22% |
| Sep 30, 2023 | 6.08% |
| Jun 30, 2023 | 6.87% |
| Mar 31, 2023 | 9.33% |
| Dec 31, 2022 | 9.73% |
| Sep 30, 2022 | 8.60% |
| Jun 30, 2022 | 8.99% |
| Mar 31, 2022 | 11.03% |
| Dec 31, 2021 | 10.57% |
| Sep 30, 2021 | 10.86% |
| Jun 30, 2021 | 10.91% |
| Mar 31, 2021 | 9.88% |
| Dec 31, 2020 | 10.00% |
| Sep 30, 2020 | -61.91% |
| Jun 30, 2020 | -63.75% |
| Mar 31, 2020 | -65.79% |
| Dec 31, 2019 | 18.72% |
| Sep 30, 2019 | 20.69% |
| Jun 30, 2019 | 17.52% |
| Mar 31, 2019 | 16.78% |
| Dec 31, 2018 | 10.72% |
| Sep 30, 2018 | 9.29% |
| Jun 30, 2018 | 8.84% |
| Mar 31, 2018 | 6.27% |
| Dec 31, 2017 | 5.70% |
| Sep 30, 2017 | 5.95% |
| Jun 30, 2017 | 6.51% |
| Mar 31, 2017 | 5.30% |
| Dec 31, 2016 | 5.18% |
| Sep 30, 2016 | 4.94% |
| Jun 30, 2016 | 5.25% |
| Mar 31, 2016 | 2.89% |
| Dec 31, 2015 | 0.86% |
| Sep 30, 2015 | -0.60% |
| Jun 30, 2015 | -3.26% |
| Mar 31, 2015 | -6.34% |
| Dec 31, 2014 | -6.43% |
| Sep 30, 2014 | -6.75% |
| Jun 30, 2014 | -7.40% |